[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353509-105":59,"doc-detail-353509-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","new-quinoline-kinase-inhibitors-with-good-selectivity-for-nak-kinases-and-anti-tumor-activity-against-ewing-sarcoma","New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti-Tumor Activity Against Ewing Sarcoma","","Novel 4,6-disubstituted quinoline derivatives were identified from an in-house quinoline library as promising anti-proliferative agents against Ewing sarcoma. Kinase panel evaluation showed generally narrow selectivity for this compound class, with the main inhibited targets belonging to the NAK family. Cyclin G-associated kinase (GAK) was inhibited in the nanomolar range in enzyme kinetic assays, supporting further optimization for childhood cancer therapeutic development.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/new-quinoline-kinase-inhibitors-with-good-selectivity-for-nak-kinases-and-anti-tumor-activity-against-ewing-sarcoma/353509/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/new-quinoline-kinase-inhibitors-with-good-selectivity-for-nak-kinases-and-anti-tumor-activity-against-ewing-sarcoma/353509.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What compounds were developed for Ewing sarcoma treatment in this study?","Question",{"text":112,"@type":113},"The study identified a series of new 4,6-disubstituted quinoline derivatives from an in-house quinoline chemical library.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How selective were the quinoline derivatives across the kinase panel?",{"text":117,"@type":113},"Evaluation against a panel of kinases showed generally narrow selectivity profiles for this compound class.",{"name":119,"@type":110,"acceptedAnswer":120},"Which NAK-family kinase showed the strongest inhibition and at what potency?",{"text":121,"@type":113},"Cyclin G-associated kinase (GAK) was inhibited at nanomolar range in enzyme kinetic assays.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353509,1790617926,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Archiv der Pharmazie   \n FULL PAPER   \nNew Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti‐Tumor Activity Against Ewing Sarcoma  \nCaroline de Bem Gentz1,2 | Thais Helena Maciel Fernandes1,2 | Marcela Silva Lopes3,4 | Lewis Elson5 | Andreas Krämer5 | Lucas Rodrigo de Souza6 | Isadora Serraglio Fortes1,2,4 | Geórgia Silva Pinto2 | Martha Cestari Silva Martins1,2 | Henrique Barros de Lima1,2 | André da Silva Santiago6 | Lauro José Gregianin4,7,8,9 | Katlin Brauer Massirer6 |  \nMário Henrique Bengtson6 | Rafael Roesler3,4,7 | Stefan Knapp5 | Stefan A. Laufer10 | Saulo Fernandes de Andrade1,2,4  1Pharmaceutical Sciences Graduate Program, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil | 2Pharmaceutical Synthesis Group (PHARSG), School of Pharmacy, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul,  \nBrazil | 3Department of Pharmacology, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil | 4National Science and Technology Institute for Children′s Cancer Biology and Pediatric Oncology ‐ INCT BioOncoPed, Porto Alegre, Brazil | 5Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt, am Main, Germany | 6Center for Medicinal Chemistry (CQMED), Center for Molecular Biology and Genetic Engineering (CBMEG), University of Campinas (UNICAMP), Campinas, São Paulo, Brazil | 7Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE‐HCPA), Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil | 8Department of Pediatrics, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil | 9Pediatric Oncology Service, Clinical Hospital, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil | 10Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Sciences, University of Tübingen, Tübingen, Germany  \nCorrespondence: Stefan A. Laufer ([stefan.laufer@uni-tuebingen.de](stefan.laufer@uni-tuebingen.de)) | Saulo Fernandes de Andrade ([saulo.fernandes@ufrgs.br](saulo.fernandes@ufrgs.br))  \nReceived: 24 September 2025 | Revised: 26 November 2025 | Accepted: 23 December 2025  \nFunding: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Grant/Award Number: Finance Code 001; Conselho Nacional de Desenvolvimento Científico e Tecnológico, Grant/Award Numbers: 307104/2025‐7, 406484/2022‐8, 446573/2025‐6; Fundação de Amparo à Pesquisa do Estado do R.S., Grant/Award Number: 24/2551‐0001376‐8; Fundação de Amparo à Pesquisa do Estado de São Paulo, Grant/Award Numbers: 2013/50724−5, 2014/50897−0, 2020/16094‐8, 2024/09297‐0; Structural Genomics Consortium, Grant/Award Number: 1097737; EUbOPEN, Grant/Award Number: 875510; Frankfurt Cancer Institute  \nKeywords: Ewing Sarcoma | GAK | inhibitor | panel of kinases | quinoline  \nABSTRACT  \nIn the past few years, several novel anticancer agents targeting protein kinases have been discovered expanding the available therapeutic arsenal. However, few new therapeutic approaches have been developed for the treatment of childhood cancer. To this end, we have been making efforts to contribute to this important field. Herein, we identified a series of new 4,6‐disubstituted quinoline derivatives from our in‐house quinoline chemical library that showed promising anti‐proliferative activity against Ewing Sarcoma (ES) . This interesting observation engaged us to further investigate these derivatives since this type of cancer is among the most common bone cancers in children. Evaluation of the quinoline derivatives against a panel of kinases demonstrated generally narrow selectivity profiles of this compound class. Interestingly, the main kinases that were inhibited belonged to the NAK family of kinases, in particular, the family member cyclin G‐associated kinase (GAK) which was inhibite","cbCaikD9BCYcYuCy","https://ap.wps.com/l/cbCaikD9BCYcYuCy","pdf",2957058,16,"English","# Abstract\n# Introduction","[{\"question\":\"What compounds were developed for Ewing sarcoma treatment in this study?\",\"answer\":\"The study identified a series of new 4,6-disubstituted quinoline derivatives from an in-house quinoline chemical library.\"},{\"question\":\"How selective were the quinoline derivatives across the kinase panel?\",\"answer\":\"Evaluation against a panel of kinases showed generally narrow selectivity profiles for this compound class.\"},{\"question\":\"Which NAK-family kinase showed the strongest inhibition and at what potency?\",\"answer\":\"Cyclin G-associated kinase (GAK) was inhibited at nanomolar range in enzyme kinetic assays.\"}]","New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti-Tumor Activity Against Ewing Sarcoma | PDF",1790105858,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57a6c95ea349dd16940481e18ec9cb66.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d144452c2a837761b2f25f868c5701d.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ecabc3a25724787ba78e80fe546ee93.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/902e911565260315c801503c642a2560.webp",980,1287]